Open AccessToxoplasma ROP16I/III ameliorated inflammatory bowel diseases via inducing M2 phenotype of macrophages
Author(s) -
Yong-Wei Xu,
Rui-Xin Xing,
Wenhui Zhang,
Lü Li,
Yi Wu,
Jing Hu,
Cong Wang,
Qingli Luo,
Jilong Shen,
Xi Chen
Publication year - 2019
Publication title -
world journal of gastroenterology
Language(s) - Uncategorized
Resource type - Journals
SCImago Journal Rank - 1.427
H-Index - 155
eISSN - 2219-2840
pISSN - 1007-9327
DOI - 10.3748/wjg.v25.i45.6634
Subject(s) - tumor necrosis factor alpha , microbiology and biotechnology , inflammatory bowel disease , lipopolysaccharide , interleukin , nitric oxide synthase , inflammation , macrophage , biology , chemistry , immunology , cytokine , nitric oxide , medicine , in vitro , pathology , endocrinology , biochemistry , disease
Inflammatory bowel disease (IBD) is characterized by chronic and non-specific inflammation of the intestinal mucosa and mainly includes ulcerative colitis and Crohn's disease.